|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0013230,
umls-concept:C0021201,
umls-concept:C0030705,
umls-concept:C0045093,
umls-concept:C0075616,
umls-concept:C0079083,
umls-concept:C0203939,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C1512162,
umls-concept:C2603343,
umls-concept:C2698018,
umls-concept:C2700456
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-4-5
|
|
pubmed:abstractText |
Carboplatin and gemcitabine are one standard regimen for patients with advanced non-small cell lung cancer (NSCLC). The oral proapoptotic agent exisulind is a cyclic guanosine monophosphate phosphodiesterase that increases apoptosis in vitro. We performed a phase II trial of carboplatin and gemcitabine with exisulind in patients with advanced NSCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
673-8
|
|
pubmed:dateRevised |
2008-5-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17409935-Adult,
pubmed-meshheading:17409935-Aged,
pubmed-meshheading:17409935-Aged, 80 and over,
pubmed-meshheading:17409935-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17409935-Carboplatin,
pubmed-meshheading:17409935-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17409935-Deoxycytidine,
pubmed-meshheading:17409935-Female,
pubmed-meshheading:17409935-Humans,
pubmed-meshheading:17409935-Lung Neoplasms,
pubmed-meshheading:17409935-Male,
pubmed-meshheading:17409935-Middle Aged,
pubmed-meshheading:17409935-Sulindac,
pubmed-meshheading:17409935-Survival Rate
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501).
|
|
pubmed:affiliation |
Christiana Care CCOP, Newark, Delaware, USA.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
